Gyre Therapeutics, Inc. (GYRE) Total liabilities 2017–2025
Gyre Therapeutics, Inc. (GYRE) total liabilities at each fiscal year-end, per SEC filings.
$31.4MFY2025 · since FY2017: $8.7M → $31.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $31.4M | +16.3% |
| FY2024 | $27.0M | -29.1% |
| FY2023 | $38.1M | +203.6% |
| FY2022 | $12.5M | -14.0% |
| FY2021 | $14.6M | -22.4% |
| FY2020 | $18.8M | — |
| FY2018 | $5.0M | -43.1% |
| FY2017 | $8.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice